Reblozyl 75 mg powder for solution for injection
220752
Phase 2 small_molecule active
Quick answer
Reblozyl 75 mg powder for solution for injection for Myelofibrosis is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Myelofibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active